CD8A and sarcoma: IL‐12 is known to stimulate production of TNF‐α by T cells and NK cells and combinations of IL‐12 and TNF‐α have been shown to induce CD8+ T cell and NK cell‐dependent antitumor immune responses in murine models of melanoma and sarcoma.2, 43